株式会社バイオロジカ

03/06/2026

CD Bioparticles offers rapid and convenient cell isolation kits designed to efficiently isolate highly purified cell populations from various biological suspensions, including B cells, T cells, and stem cells. These magnetic cell isolation kits are characterized by high binding capacity, excellent purity and recovery rates, strong compatibility, and low toxicity.
https://www.cd-bioparticles.com/product/cell-isolation-list-6.html

02/06/2026

CD Bioparticles has developed magnetic particle-based AAV Purification Kits using affinity principles. These kits are designed for the preparation of high-purity AAV suitable for research applications and early-stage development projects. We also supply AAV purification agarose particles as affinity chromatography mediums for the purification of AAV.
https://www.cd-bioparticles.com/products/virus-purification-kit-2148.html

01/06/2026

29/05/2026

CD Bioparticles offers customized vaccine development services based on Spontaneous Nanoliposome Antigen Particles (SNAP) technology, a platform that achieves extremely high antigen delivery efficiency and immune activation capabilities and has demonstrated excellent performance in a variety of candidate vaccines.
https://www.cd-bioparticles.net/services/spontaneous-nanoliposome-antigen-particles-for-rapid-potent-vaccine-development.html

28/05/2026

Exploring the Potential of Listeria monocytogenes-Based Vaccines in Immunotherapy

As an intracellular bacterial vector, Listeria monocytogenes has emerged as a promising platform for vaccine development and cancer immunotherapy due to its strong ability to stimulate both innate and adaptive immune responses.

At Creative Diagnostics, we provide comprehensive research solutions supporting Listeria monocytogenes vaccine studies, including:

✔ High-quality antibodies & antigens
✔ Immunoassay development support
✔ Rapid test solutions
✔ Research tools for bacterial pathogenesis and immune response studies

Discover how attenuated Listeria monocytogenes strains are advancing next-generation vaccine strategies and cancer immunotherapy research.

Learn more: https://www.creative-diagnostics.com/listeria-monocytogenes-based-vaccines.htm

27/05/2026

Glycan motifs are capable of mediating biological recognition; however, how their structural features modulate the biodistribution and immune responses of lipid nanoparticles (LNPs) remains to be explored. In light of this, Shaoyi Jiang at Cornell University systematically investigated the impact of glycan structure on the biodistribution and immune responses of LNPs within the context of controllable, commercially available formulations.
https://www.cd-bioparticles.net/products/drug-loaded-nanoparticles-2396.html

26/05/2026

Creative Diagnostics offers a comprehensive portfolio of hantavirus research reagents:

✅ Monoclonal & Polyclonal Antibodies (N protein, Gn/Gc glycoproteins)
✅ Recombinant Antigens for serological assay development
✅ IgM/IgG ELISA Kits for rapid clinical diagnosis
✅ Virus-Like Particles (VLPs) for vaccine & diagnostic research
✅ RT-PCR detection solutions

📚 Explore our full hantavirus resource hub covering virology, epidemiology, transmission, symptoms, diagnosis, and treatment strategies.

👉 Learn more: https://www.creative-diagnostics.com/hantavirus.htm

Hantavirus

25/05/2026

Membrane Protein Services
Membrane proteins such as receptors and ion channels are key regulators of cellular function. Membrane proteins account for up to two-thirds of known druggable targets, highlighting their critical pharmaceutical importance. Creative BioMart has been working with pharmaceutical, biotechnology, and academic customers and collaborators, providing membrane protein-related products and services.
https://www.creativebiomart.net/membrane-protein-services.htm

21/05/2026

Lipid Changes Happen Hours After Drug Exposure — Before Genes Even Respond. Here's How We Measure Them.

Here's something most drug discovery teams don't track: lipid remodeling.

It happens fast — within hours of drug exposure, well before transcriptional changes. It can reveal how a drug works, flag toxicity risks like phospholipidosis, and uncover resistance mechanisms that genomics alone misses.

Creative Proteomics' Cellular Lipidomics Drug Profiling service is built specifically for this.

What we cover:

🧬 500+ lipid species across 15+ classes. Glycerophospholipids, sphingolipids, sterols, glycerolipids, fatty acids, bioactive lipids — with isomer-level resolution.

🔬 Dual-column LC-MS/MS. HILIC separates by class. RP separates by species. Together they give you the full picture.

🎯 Seven analysis modes. Untargeted discovery, targeted quantification, toxicity screening, cancer vulnerability analysis, signaling lipid profiling, and more.

📊 Drug-tailored experimental design. Dose-response, time course, multiple replicates. Designed for discovery, not just description.

Real example: A 2025 study used this approach to show that FOLFOXIRI-resistant colorectal cancer cells share a common lipid remodeling program across four different cell lines — increased membrane saturation, altered ceramide signaling — that genomic analysis alone could not detect.

Minimum input: 1×10⁶ cells (micro-extraction). Turnaround: 4–6 weeks.

Learn more: creative-proteomics.com/mass-target/cellular-lipidomics-profiling.htm